Xencor
XNCR
A$13.54
Share price
-2.33%
Change (1 day)
-57.86%
Change (1 year)
Categories
Xencor (XNCR) - Cash on Hand
Cash on Hand as of March 2025 : A$0.72 Billion
According to Xencor's latest financial reports the company has A$0.72 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Xencor - Cash on Hand chart (from 2012 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$0.80 B | -8.17% |
| 2023-12-31 | A$0.87 B | -4.82% |
| 2022-12-31 | A$0.91 B | 98.67% |
| 2021-12-31 | A$0.46 B | -41.23% |
| 2020-12-31 | A$0.78 B | 3.64% |
| 2019-12-31 | A$0.75 B | 81.09% |
| 2018-12-31 | A$0.41 B | 45.55% |
| 2017-12-31 | A$0.28 B | 59.02% |
| 2016-12-31 | A$0.18 B | 36.39% |
| 2015-12-31 | A$0.13 B | 98.23% |
| 2014-12-31 | A$66.77 M | -23.61% |
| 2013-12-31 | A$87.41 M | 3829.26% |
| 2012-12-31 | A$2.22 M | -84.31% |
| 2011-12-31 | A$14.17 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | A$1.89 B | 163.43% | 🇺🇸 USA |
 MacroGenics MGNX | A$0.23 B | -67.17% | 🇺🇸 USA |
 Amgen AMGN | A$13.51 B | 1,776.20% | 🇺🇸 USA |
 Merck MRK | A$14.16 B | 1,865.22% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$59.51 B | 8,158.90% | 🇺🇸 USA |
 AbbVie ABBV | A$7.94 B | 1,002.29% | 🇺🇸 USA |